|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/00 |
| (11) | Number of the document | 1853700 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06706455.0 |
| Date of filing the European patent application | 2006-01-27 | |
| (97) | Date of publication of the European application | 2007-11-14 |
| (45) | Date of publication and mention of the grant of the patent | 2012-10-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2006/000734 |
| Date | 2006-01-27 |
| (87) | Number | WO 2006/089613 |
| Date | 2006-08-31 |
| (30) | Number | Date | Country code |
| 657041 P | 2005-02-28 | US |
| (72) |
SCHEIFLINGER, Friedrich, AT
BOEHM, Ernst, AT
|
| (73) |
Baxter International Inc.,
One Baxter Parkway, Deerfield, IL 60015,
US
Baxter Healthcare SA, Thurgauerstrasse 130, 8152 Glattpark (Opfikon), CH |
| (54) | RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSION |
| RECOMBINANT CO-EXPRESSION OF VITAMIN K EPOXIDE REDUCTASE SUBUNIT 1 TO IMPROVE VITAMIN K DEPENDENT PROTEIN EXPRESSION |